Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma
Status:
Unknown status
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of sunitinib in non-clear cell type renal cell carcinoma
with the exception of pure sarcomatoid carcinoma and collecting duct carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Asan Medical Center
Collaborators:
Kyungpook National University Kyungpook National University Hospital Samsung Medical Center Seoul National University Hospital